✦ LIBER ✦

Chemoprotection by 9-aminoacridine derivatives against the cytotoxicity of topoisomerase II-directed drugs

✍ Scribed by Finlay, Graeme J.; Wilson, William R.; Baguley, Bruce C.

Book ID: 122068105
Publisher: Elsevier Science
Year: 1989
Weight: 837 KB
Volume: 25
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(89)90337-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potentiation by phenylbisbenzimidazoles

Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II

✍ Finlay, Graeme J.; Baguley, Bruce C. 📂 Article 📅 1990 🏛 Elsevier Science ⚖ 515 KB

Inhibition of the Topoisomerase II-DNA C

Inhibition of the Topoisomerase II-DNA Cleavable Complex by theortho-Quinone Derivative of the Antitumor Drug Etoposide (VP-16)

✍ Tsvetan G. Gantchev; Darel J. Hunting 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Antagonistic effect of the cardioprotect

Antagonistic effect of the cardioprotector (+)-1,2-BIS(3,5-dioxopiperazinyl-1-YL)propane(ICRF-187) on dna breaks and cytotoxicity induced by the topoisomerase ii directed drugs daunorubicin and etoposide (VP-16)

✍ Maxwell Sehested; Peter Buhl Jensen; Boe Sandahl Sørensen; Bente Holm; Ellen Fri 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 520 KB

Characterisation of cytotoxicity and DNA

Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells

✍ Lars H Jensen; Marielle Dejligbjerg; Lasse T Hansen; Morten Grauslund; Peter B J 📂 Article 📅 2004 🏛 BioMed Central 🌐 English ⚖ 748 KB

## Background Bisdioxopiperazine anti-cancer agents are inhibitors of eukaryotic DNA topoisomerase II, sequestering this protein as a non-covalent protein clamp on DNA. It has been suggested that such complexes on DNA represents a novel form of DNA damage to cells. In this report, we characterise t

Evidence of involvement of cytotoxic ant

Evidence of involvement of cytotoxic antibodies directed against patient’s HLA class II produced by transfused donor-derived B cells in post-transfusion graft-versus-host disease

✍ Motoko Nishimura; Shigeharu Uchida; Shigeki Mitsunaga; Katsushi Tokunaga; Kenji 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Sister-chromatid exchanges, chromosomal

Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: Correlations with the formation of DNA double-strand breaks

✍ Elvira Noviello; MariaGrazia Aluigi; Guido Cimoli; Elisabetta Rovini; Alessandra 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 625 KB